Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: A long-term follow-up

References

• WHO/IUIS Notice. Appropriate uses of human immunoglobulin in clinical practice. Clin Exp Immunol 1983; 52: 417–22
   PubMed Web of Science ®Google Scholar
• Primary Immunodeficiency Diseases. WHO Scientific Group. Primary immunodeficiency diseases. Immunodef Rev 1992; 3: 195–236
   PubMedGoogle Scholar
• Primary Immunodeficiency Diseases. Report of an IUIS Scientific Group. Clin Exp Immunol 1999; 118(Suppl 1)1–28
   Google Scholar
• Jefferis R, Kumararatne DS. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol 1990; 81: 357–67
   PubMed Web of Science ®Google Scholar
• Hanson, LÅ, Söderström, T, Oxelius, VA, editors. Immunoglobulin Subclass Deficiencies. Basel: Karger; 1986.
   Google Scholar
• Lacombe C, Aucouturier P, Preud'homme J-L. Selective IgG1 deficiency. Clin Immunol Immunopathol 1997; 84: 194–201
   PubMedGoogle Scholar
• Morell A. IgG subclass deficiency: a personal viewpoint. Pediatr Infect Dis J 1990; 9: S4–8
   PubMed Web of Science ®Google Scholar
• Halpern GM. Critical evaluation of the clinical relevance of the IgG subclasses assays. Allerg Immunol (Paris) 1993; 25: 10–8
   PubMedGoogle Scholar
• Herrod HG. Management of the patient with IgG subclass deficiency and/or selective antibody deficiency. Ann Allergy 1993; 70: 3–8
   PubMedGoogle Scholar
• Buckley RH. Immunoglobulin G subclass deficiency: fact or fancy?. Curr Allergy Asthma Rep 2002; 2: 356–60
   PubMedGoogle Scholar
• Cunningham-Rundles C. Immune deficiency: office evaluation and treatment. Allergy Asthma Proc 2003; 24: 409–15
   PubMed Web of Science ®Google Scholar
• Berger M. Immunoglobulin G subclass determination in diagnosis and management of antibody deficiency syndromes. J Pediatr 1987; 110: 325–8
   PubMed Web of Science ®Google Scholar
• O'Connor ME, Kirkpatrick CH. Management of IgG subclass deficiency in adults. Infect Med 2003; 20: 596–602
   Google Scholar
• Beard LJ, Ferrante A. Aspects of immunoglobulin replacement therapy. Pediatr Infect Dis J 1990; 9: S54–61
   PubMed Web of Science ®Google Scholar
• Björkander J, Bengtsson U, Oxelius V-A, Hanson LÅ. Symptoms in patients with lowered levels of IgG subclasses, with or without IgA deficiency, and effects of immunoglobulin prophylaxis. Monogr Allergy 1986; 20: 157–63
   PubMedGoogle Scholar
• Knutsen A. Patients with IgG subclass and/or selective antibody deficiency to polysaccharide antigens: initiation of a controlled clinical trial of intravenous immune globulin. J Allergy Clin Immunol 1989; 84: 640–7
   PubMed Web of Science ®Google Scholar
• Söderström R, Söderström T, Lindholm NB, Hanson LÅ. Effect of immunoglobulin prophylaxis in infection-prone adults with low IgG-subclass levels: a single-blind crossover study. Immunol and Infect Dis 1996; 6: 197–201
   Google Scholar
• IUIS/WHO Working group. Laboratory investigations in clinical immunology: methods, pitfalls, and clinical indications. Clin Immunol Immunopathol 1988; 49: 478–97
   PubMedGoogle Scholar
• Gardulf A, Björvell H, Gustafson R, Hammarström L, Smith CIE. Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency. Immunodeficiency 1993; 4: 81–4
   PubMedGoogle Scholar
• Gardulf A, Andersen V, Björkander J, Ericson D, Fröland SS, Gustafson R, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 1995; 345: 365–9
   PubMed Web of Science ®Google Scholar
• Oxelius VA. Serum IgG and IgG subclass contents in different Gm phenotypes. Scand J Immunol 1993; 37: 149–53
   PubMed Web of Science ®Google Scholar
• Smith CI, Hammarstrom L, Henter JI, de Lange GG. Related Articles Links. Molecular and serological analysis of IgG1 deficiency caused by new forms of the constant region of the Ig H chain gene deletions. J Immunol 1989; 142: 4514–9
   PubMed Web of Science ®Google Scholar
• Ozkan H, Atlihan F, Genel F, Targan S, Gunvar T. IgA and/or IgG subclass deficiency in children with recurrent respiratory infections and its relationship with chronic pulmonary damage. J Invest Allergol Clin Immunol 2005; 15: 69–74
   PubMed Web of Science ®Google Scholar
• Avanzini MA, Björkander J, Söderström R, Söderström T, Schneerson R, Robbins JB, Hanson LÅ. Qualitative and quantitative analyses of the antibody response elicited by Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in adults with IgG subclass deficiencies and frequent infections. Clin Exp Immunol 1994; 96: 54–8
   PubMed Web of Science ®Google Scholar
• Nilssen DE, Söderström R, Brandtzaeg P, Kett K, Helgeland L, Karlsson G, et al. Isotype distribution of mucosal IgG-producing cells in patients with various IgG subclass deficiencies. Clin Exp Immunol 1991; 82: 17–24
   Google Scholar
• Chapel HM, Spicket GP, Ericson D, Engl W, Eibl MM, Bjorkander J. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol 2000; 20: 94–100
   PubMed Web of Science ®Google Scholar